BioMarin Pharmaceutical Inc - Company Profile
Powered by
All the data and insights you need on BioMarin Pharmaceutical Inc in one report.
- Save hours of research time and resources with
our up-to-date BioMarin Pharmaceutical Inc Strategy Report
- Understand BioMarin Pharmaceutical Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
BioMarin Pharmaceutical Inc (BioMarin) develops and commercializes innovative biopharmaceuticals for diseases with significant unmet medical needs. The growth in Vimizim’s sales, wide geographical reach, and research and development activities are the strengths of the company, even as an increase in trade receivables is a cause for concern. Strategic initiatives, broad product pipeline, and increasing healthcare expenditure provide growth opportunities to the company. However, competition in drug development coupled with the company’s heavy reliance on limited customer base for revenue generation could affect its growth and profitability.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer